Application of cycloheptatrienone in the inhibition of Botrytis cinerea and / or Anthracnose
The use of cycloheptatrienone fumigation to inhibit Botrytis cinerea and Anthracnose has solved the problems of strong dependence on chemical pesticides and pathogen resistance, achieving complete inhibition of both pathogens and providing a safe and efficient disease control solution.
Patent Information
- Application Number
- CN202611452549.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2026-09-18
- Publication Date
- 2026-11-17
AI Technical Summary
Current methods for controlling gray mold and anthracnose in peppers rely on chemical pesticides, leading to severe pesticide resistance in pathogens, high environmental risks, and limited post-harvest disease control. There is a lack of safe, efficient, and environmentally friendly biological control methods.
Cycloheptatrienone was used as the active ingredient to inhibit Botrytis cinerea and Anthracnose by fumigation at specific concentrations of 0.02-0.05 μL/mL and 0.5-1 μL/mL, achieving complete inhibition of the pathogens.
The complete inhibition of the in vitro growth of Botrytis cinerea and Anthracnose in a closed system provides a new approach to disease control and avoids the negative effects of chemical pesticides.
Smart Images

Figure CN123100613A_ABST
Abstract
Description
Technical Field
[0001] This invention relates to the field of pathogen inhibition technology, and in particular to the application of cycloheptatrienone in inhibiting Botrytis cinerea and / or Anthracnose. Background Technology
[0002] Botrytis cinerea ( Botrytis cinerea *Anthracnose* is a necrotic plant pathogen with a very wide host range, infecting more than 200 kinds of economic crops, including tomatoes, strawberries, grapes, cucumbers, and lettuce, causing gray mold. This disease is particularly severe in greenhouse agriculture and in cool, humid regions. A large amount of gray mold develops on the affected parts, leading to fruit rot, leaf death, and flower wilting, resulting in significant post-harvest losses. Due to the pathogen's latent infection and saprophytic facultative characteristics, control is extremely difficult. *Anthracnose spp.* Colletotrichum truncatum *Colletotrichum gloeosporioides*, belonging to the genus *Colletotrichum* in the subphylum Deuteromycetes, is one of the main pathogens causing anthracnose in chili peppers. It is widespread in major chili-growing areas, infecting fruits, leaves, and stems to form typical concentric ring lesions. Severe cases lead to leaf and fruit drop, directly impacting chili yield and market quality. This pathogen overwinters as conidia on diseased plant debris or seeds, spreading rapidly in the field and easily causing outbreaks under warm, humid conditions, resulting in significant economic losses to the chili industry.
[0003] Currently, the control of gray mold and anthracnose in peppers mainly relies on chemical fungicides, such as benzimidazoles (carbendazim, thiophanate-methyl), dicarboximides (iprodione, isopyrazosulfuron), methoxyacrylates (pyraclostrobin, azoxystrobin), and prochloraz. However, the long-term, large-scale, and singular use of chemical pesticides has led to serious negative effects: on the one hand, *Botrytis cinerea* and *Anthracnose spp.* have developed varying degrees of resistance to many commonly used fungicides, resulting in a year-on-year decline in field efficacy and forcing a continuous increase in dosage and frequency of application; on the other hand, chemical pesticide residues damage the soil microbial community structure, affecting the ecological balance of farmland and threatening human health through bioaccumulation in the food chain. Furthermore, chemical control has limited effectiveness in controlling postharvest diseases and faces strict pesticide residue limits, making it difficult to meet the needs of green agricultural production. Therefore, developing safe, efficient, and environmentally friendly biological control methods and novel biopesticides has become an important research direction in the field of plant disease control.
[0004] Tropone, chemically named 2,4,6-cyclohepta-2,4,6-trien-1-one (C7H6O), has a molecular weight of 106.12. Its molecular structure features a unique seven-membered ring conjugated system (2,4,6-cyclohepta-trienone skeleton), classifying it as a non-benzene aromatic compound. It exhibits significant polarity and electron delocalization, enabling it to specifically interact with biomolecules such as metal ions and enzyme active sites. In natural product chemistry, cyclohepta-trienone is the parent core structure of Troponoid compounds. Existing research suggests that derivatives of cyclohepta-trienone—particularly cyclohepta-trienolone (Tropolone, i.e., 2-hydroxycyclohepta-trienone) and its Troponoid counterpart—have shown antibacterial or antifungal activity in some studies. For example, some natural products containing a Troponoid skeleton exhibit chelating inhibition of bacterial metalloenzymes (such as copper-dependent oxidases) or interfere with electron transport in the fungal respiratory chain. However, it must be emphasized that in medicinal and pesticide chemistry, there is no necessary equivalence or predictability in the biological activity of the parent compound and its derivatives. The introduction of hydroxyl, alkyl, or other substituents into derivatives can significantly alter the molecule's lipid-water partition coefficient, target affinity, membrane permeability, and metabolic stability, leading to substantial differences in activity profiles, potency, and selectivity. For instance, cycloheptatrienones exhibit significantly greater biological activity than unsubstituted cycloheptatrienones. Therefore, the reported antibacterial activity of cycloheptatrienones and other derivatives cannot replace or be extrapolated to direct experimental verification of cycloheptatrienones themselves against specific plant pathogens.
[0005] A comprehensive search of existing technical literature revealed no direct and systematic research reports on the inhibitory effects, mechanisms of action, and application methods of cycloheptatrienone against *Botrytis cinerea* and *Anthracnose spp.*, or in the control of plant diseases. Existing technologies neither disclose data on the antifungal activity of cycloheptatrienone against these two pathogens nor provide specific application techniques for its use in the field to control gray mold or anthracnose in peppers. This technological gap means that those skilled in the art cannot predict whether cycloheptatrienone possesses inhibitory activity against *Botrytis cinerea* and *Anthracnose spp.* from existing general studies of Troponoid compounds, let alone determine its effective concentration, application method, and actual control effect.
[0006] In summary, existing methods for controlling gray mold and anthracnose in peppers suffer from significant drawbacks, including strong reliance on chemical pesticides, increasingly serious pathogen resistance, unstable control efficacy, and high environmental risks. Furthermore, the bioactivity and field application technology of cycloheptatrienone against these two important pathogens remain unknown. Therefore, there is an urgent need to develop novel, safe, efficient, and environmentally friendly disease control strategies using cycloheptatrienone as the active ingredient to fill existing technological gaps and provide new technological options for the green control of gray mold and anthracnose in peppers. Summary of the Invention
[0007] The purpose of this invention is to provide the application of cycloheptatrienone in inhibiting *Botrytis cinerea* and / or *Anthracis chinensis*, in order to solve the problems existing in the prior art. Cycloheptatrienone exhibits complete inhibitory effects on both *Botrytis cinerea* and *Anthracis chinensis*. This invention provides a new means and approach for the inhibition of *Botrytis cinerea* and *Anthracis chinensis*.
[0008] To achieve the above objectives, the present invention provides the following solution: This invention provides cycloheptatrienone for inhibiting Botrytis cinerea (… Botrytis cinerea ) and / or flathead anthrax bacteria ( Colletotrichum truncatum Applications in ).
[0009] The present invention also provides the use of cycloheptatrienone in the preparation of products that inhibit Botrytis cinerea and / or Anthracnose.
[0010] Optionally, the product includes a fumigation-type disinfectant.
[0011] The present invention also provides a method for inhibiting Botrytis cinerea, comprising the step of fumigating the Botrytis cinerea with cycloheptatrienone.
[0012] Optionally, the concentration of the cycloheptatrienone is 0.02-0.05 μL / mL.
[0013] The present invention also provides a method for inhibiting *Anthrax flavomarginata*, comprising the step of fumigating the *Anthrax flavomarginata* with cycloheptatrienone.
[0014] Optionally, the concentration of the cycloheptatrienone is 0.5-1 μL / mL.
[0015] The present invention also provides the use of cycloheptatrienone in the control of plant diseases caused by Botrytis cinerea and / or Anthracnose.
[0016] The present invention also provides the use of cycloheptatrienone in the preparation of products for the prevention and control of plant diseases caused by Botrytis cinerea and / or Anthracnose.
[0017] Optionally, the product includes a fumigation-type disinfectant.
[0018] The present invention discloses the following technical effects: This invention evaluates the antibacterial effect of cycloheptatrienone in a closed PDA plate system, achieving complete inhibition of its in vitro growth without direct contact with the pathogenic culture medium. The technical effectiveness of this invention is demonstrated by the following experimental data: (1) Under the treatment of 0.05 μL / mL cycloheptatrienone, the colony diameter of Botrytis cinerea was 0.00 mm throughout the entire culture period (day 2 and day 3), while the colony diameter of the control group reached 31.42 mm (day 2) and 68.72 mm (day 3), respectively, indicating that the treatment could completely inhibit the in vitro growth of Botrytis cinerea; (2) Under the treatment of 1 μL / mL cycloheptatrienone, the colony diameter of Anthracnose spp. was 0.00 mm throughout the entire culture period (day 2 and day 3), while the colony diameter of the control group reached 20.13 mm (day 2) and 37.24 mm (day 3), respectively, indicating that the treatment could completely inhibit the in vitro growth of Anthracnose spp.
[0019] The above results demonstrate that cycloheptatrienone exhibits complete inhibitory activity against both tested pathogens. This invention provides a new method and approach for the inhibition of *Botrytis cinerea* and *Anthracis chinensis*. Attached Figure Description
[0020] To more clearly illustrate the technical solutions in the embodiments of the present invention or the prior art, the drawings used in the embodiments will be briefly introduced below. Obviously, the drawings described below are only some embodiments of the present invention. For those skilled in the art, other drawings can be obtained based on these drawings without creative effort.
[0021] Figure 1 0.02 μL / mL of cycloheptatrienone B.cinerea The impact on colony growth; Figure 2 0.05 μL / mL of cycloheptatrienone B.cinerea The impact of colony growth; A: Colony diagram; B: Colony diameter statistics; Figure 3 0.5 μL / mL of cycloheptatrienone C. truncatum The impact on colony growth; Figure 4 1 μL / mL of cycloheptatrienone C. truncatum The impact on colony growth; A: Colony diagram; B: Colony diameter statistics. Detailed Implementation
[0022] Various exemplary embodiments of the present invention will now be described in detail. This detailed description should not be considered as a limitation of the present invention, but rather as a more detailed description of certain aspects, features, and embodiments of the present invention.
[0023] It should be understood that the terminology used in this invention is merely for describing particular embodiments and is not intended to limit the invention. Furthermore, with respect to numerical ranges in this invention, it should be understood that each intermediate value between the upper and lower limits of the range is also specifically disclosed. Any stated value or intermediate value within a stated range, as well as each smaller range between any other stated value or intermediate value within said range, is also included in this invention. The upper and lower limits of these smaller ranges may be independently included or excluded from the range.
[0024] Unless otherwise stated, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art. While only preferred methods and materials have been described herein, any methods and materials similar or equivalent to those described herein may be used in the implementation or testing of this invention. All references to this specification are incorporated by way of citation to disclose and describe methods and / or materials associated with those references. In the event of any conflict with any incorporated reference, the content of this specification shall prevail.
[0025] Various modifications and variations can be made to the specific embodiments described in this specification without departing from the scope or spirit of the invention, as will be apparent to those skilled in the art. Other embodiments derived from this specification will also be obvious to those skilled in the art. This specification and embodiments are merely exemplary.
[0026] The terms “include,” “including,” “have,” “contain,” etc., used in this article are all open-ended terms, meaning that they include but are not limited to.
[0027] Example 1 Cycloheptatrienone against Botrytis cinerea ( Botrytis cinerea Inhibition of in vitro growth 1. Experimental materials Test pathogen: Botrytis cinerea ( Botrytis cinerea (ATCC 58025); Cycloheptatrienone standard (CAS No. 539-80-0), purchased from Maclean's Reagent Company; sterilized round filter paper; PDA medium (potato dextrose agar).
[0028] 2. Experimental Methods After culturing *Botrytis cinerea* on PDA plates at 25°C for 3 days, 3 mm diameter hyphal blocks were taken from the edge of the hyphae using a punch. These hyphal blocks were inoculated into the center of a new PDA plate. A sterile circular filter paper was fixed to the inner surface of the plate lid. Liquid cycloheptatrienone at concentrations of 0.02 μL / mL or 0.05 μL / mL was then added dropwise to the filter paper using a pipette. The plate was quickly covered and inverted (avoiding direct contact between the drug and the PDA medium). The treatment without cycloheptatrienone served as a control. The plates were incubated upside down at 25°C. Colony diameters were counted using a cross-hatching method on days 2 and 3. Each treatment was replicated in triplicate.
[0029] 3. Experimental Results The inhibitory effect of 0.02 μL / mL cycloheptatrienone on Botrytis cinerea is as follows: Figure 1 As shown, compared with the control group, the colony growth of *Botrytis cinerea* was not completely inhibited by treatment with 0.02 μL / mL cycloheptatrienone. On day 2 of culture, the colony diameter in the control group was 38.43 mm, while the colony diameter in the 0.02 μL / mL cycloheptatrienone-treated group was 13.03 mm; on day 3 of culture, the colony diameter in the control group was 65.00 mm, while the colony diameter in the 0.02 μL / mL cycloheptatrienone-treated group was 20.50 mm. Throughout the entire culture period (0–3 days), treatment with 0.02 μL / mL cycloheptatrienone failed to completely inhibit the in vitro growth of *Botrytis cinerea*.
[0030] The inhibitory effect of 0.05 μL / mL cycloheptatrienone on Botrytis cinerea is as follows: Figure 2 As shown, compared with the control group, the colony growth of *Botrytis cinerea* was completely inhibited by treatment with 0.05 μL / mL cycloheptatrienone. On day 2 of culture, the colony diameter in the control group was 31.42 mm, while the colony diameter in the 0.05 μL / mL cycloheptatrienone-treated group was 0.00 mm; on day 3 of culture, the colony diameter in the control group was 68.72 mm, while the colony diameter in the 0.05 μL / mL cycloheptatrienone-treated group remained at 0.00 mm. Throughout the entire culture period (0–3 days), treatment with 0.05 μL / mL cycloheptatrienone completely inhibited the in vitro growth of *Botrytis cinerea*.
[0031] Example 2 Cycloheptatrienone against Anthracnose ( Colletotrichum truncatum Inhibition of in vitro growth 1. Experimental materials Test pathogen: Anthracnose bacterium ( Colletotrichum truncatumThe following items were donated by Researcher Zhang Xiaofen of the Vegetable Research Institute of Beijing Academy of Agricultural and Forestry Sciences: Cycloheptatrienone standard (CAS No. 539-80-0), purchased from Maclean's Reagent Company; sterilized round filter paper; and PDA culture medium.
[0032] 2. Experimental Methods After culturing *Anthrax spp.* on PDA plates at 25°C for 3 days, 3 mm diameter hyphal blocks were taken from the edge of the hyphae using a punch. These hyphal blocks were inoculated into the center of a new PDA plate. A sterile circular filter paper was fixed to the inner surface of the plate lid. Liquid cycloheptatrienone at concentrations of 0.5 μL / mL or 1 μL / mL was then added dropwise to the filter paper using a pipette. The plate was quickly covered and inverted (avoiding direct contact between the drug and the PDA medium). The treatment without cycloheptatrienone served as a control. The plates were incubated upside down at 25°C. Colony diameters were counted using a cross-hatching method on days 2 and 3. Each treatment was replicated in triplicate.
[0033] 3. Experimental Results The inhibitory effect of 0.5 μL / mL cycloheptatrienone on *Anthracis chinensis* is as follows: Figure 3 As shown, compared with the control group, the colony growth of *Anthracis chinensis* was not completely inhibited by treatment with 0.5 μL / mL cycloheptatrienone. On day 2 of culture, the colony diameter in the control group was 25.36 mm, while the colony diameter in the 0.5 μL / mL cycloheptatrienone-treated group was 6.06 mm; on day 3 of culture, the colony diameter in the control group was 38.13 mm, while the colony diameter in the 0.5 μL / mL cycloheptatrienone-treated group was 8.81 mm. Throughout the entire culture period (0–3 days), treatment with 0.5 μL / mL cycloheptatrienone failed to completely inhibit the in vitro growth of *Anthracis chinensis*.
[0034] The inhibitory effect of 1 μL / mL cycloheptatrienone on Anthracnose bacillus is as follows: Figure 4 As shown, compared with the control group, the colony growth of *Anthracis chinensis* was completely inhibited by treatment with 1 μL / mL cycloheptatrienone. On day 2 of culture, the colony diameter in the control group was 20.13 mm, while the colony diameter in the 1 μL / mL cycloheptatrienone-treated group was 0.00 mm; on day 3 of culture, the colony diameter in the control group was 37.24 mm, while the colony diameter in the 1 μL / mL cycloheptatrienone-treated group remained at 0.00 mm. Throughout the entire culture period (0–3 days), treatment with 1 μL / mL cycloheptatrienone completely inhibited the in vitro growth of *Anthracis chinensis*.
[0035] In summary, this invention evaluates the antibacterial effect of cycloheptatrienone in a closed PDA plate system, achieving complete inhibition of its in vitro growth without direct contact with the pathogenic culture medium. The technical effectiveness of this invention is demonstrated by the following experimental data: (1) Under the treatment of 0.05 μL / mL cycloheptatrienone, the colony diameter of Botrytis cinerea was 0.00 mm throughout the entire culture period (day 2 and day 3), while the colony diameter of the control group reached 31.42 mm (day 2) and 68.72 mm (day 3), respectively, indicating that the treatment could completely inhibit the in vitro growth of Botrytis cinerea; (2) Under the treatment of 1 μL / mL cycloheptatrienone, the colony diameter of Anthracnose spp. was 0.00 mm throughout the entire culture period (day 2 and day 3), while the colony diameter of the control group reached 20.13 mm (day 2) and 37.24 mm (day 3), respectively, indicating that the treatment could completely inhibit the in vitro growth of Anthracnose spp.
[0036] The above results demonstrate that cycloheptatrienone exhibits complete inhibitory activity against both tested pathogens. This invention provides a new method and approach for the inhibition of *Botrytis cinerea* and *Anthracis chinensis*.
[0037] The embodiments described above are merely preferred embodiments of the present invention and are not intended to limit the scope of the present invention. Various modifications and improvements made by those skilled in the art to the technical solutions of the present invention without departing from the spirit of the present invention should fall within the protection scope defined by the claims of the present invention.
Claims
1. Cycloheptatrienone inhibits the growth of Botrytis cinerea (… Botrytis cinerea ) and / or flathead anthrax bacteria ( Colletotrichum truncatum Applications in ).
2. Application of cycloheptatrienone in the preparation of products that inhibit Botrytis cinerea and / or Anthracnose.
3. The application as described in claim 2, characterized in that, The product includes a fumigation-type bactericide.
4. A method for inhibiting Botrytis cinerea, characterized in that, The step includes fumigating the *Botrytis cinerea* with cycloheptatrienone.
5. The method as described in claim 4, characterized in that, The concentration of the cycloheptatrienone is 0.02-0.05 μL / mL.
6. A method for inhibiting *Anthrax flavomarginata*, characterized in that, The step includes fumigating the *Anthrax flavomarginata* with cycloheptatrienone.
7. The method as described in claim 6, characterized in that, The concentration of the cycloheptatrienone is 0.5-1 μL / mL.
8. Application of cycloheptatrienone in the control of plant diseases caused by Botrytis cinerea and / or Anthracnose.
9. Application of cycloheptatrienone in the preparation of products for the prevention and control of plant diseases caused by Botrytis cinerea and / or Anthracnose.
10. The application as described in claim 9, characterized in that, The product includes a fumigation-type bactericide.
Citation Information
Patent Citations
Clamp for tube structures
CA539800A
